| Literature DB >> 23451043 |
Domenico Otranto1, Filipe Dantas-Torres, Donato de Caprariis, Giancarlo Di Paola, Viviana D Tarallo, Maria S Latrofa, Riccardo P Lia, Giada Annoscia, Edward B Breitshwerdt, Cinzia Cantacessi, Gioia Capelli, Dorothee Stanneck.
Abstract
BACKGROUND: Dogs are the main reservoir hosts of Leishmania infantum, the agent of human zoonotic visceral leishmaniosis. This study investigated the efficacy of a polymer matrix collar containing a combination of 10% imidacloprid and 4.5% flumethrin as a novel prophylactic measure to prevent L. infantum infections in young dogs from a hyper-endemic area of southern Italy, with a view towards enhancing current control strategies against both human and canine leishmaniosis. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2013 PMID: 23451043 PMCID: PMC3581506 DOI: 10.1371/journal.pone.0056374
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Incidence density rate (IDR) of leishmaniosis in dogs from the collared (A) and uncollared control (B) Groups.
| Dogs enrolled | Sampling date | Number of dogs in the cohort | Number of new cases | Dog-months of follow-up | Incidence Density rate/year (95% CI) | ||||
| A | B | A | B | A | B | A | B | ||
| Baseline | March–April 2011 | 63 | 61 | - | - | - | - | - | |
| Follow-up 1 | July 2011 | 63 | 61 | 0 | 0 | 175.8 | 136.6 | 0 | 0 |
| Follow-up 2 | September 2011 | 62 | 53 | 0 | 1 | 163.1 | 140.3 | 0 | 8.55 (1.02–16.08) |
| Follow-up 3 | November 2011 | 62 | 52 | 0 | 10 | 127.7 | 107.1 | 0 | 100 |
| Follow-up 4- final test | March 2012 | 62 | 51 | 0 | 10 | 251.1 | 174.4 | 0 | 68.82 (56.08–81.52) |
| Total | 0 | 21 | 717.6 | 558.4 | 0 | 45.13 (31.44–58.76) | |||
= dogs positive by one or more parasitological, serological and/or PCR tests.
Results at IFAT (the highest dilution titre is reported), cytological examination and PCR results for skin, bone marrow and conjunctival swabs of positive dogs at follow-up time points and the final test period.
| Dogs | September 2011 | November 2011 | March 2012 | |||||
| Serology | Serology | PCR | Cytology | Serology | PCR | |||
| Skin | Skin | Bone marrow | Conjunctival swabs | |||||
| Dog1 | − | − | − | − | − | + | − | − |
| Dog 2* | − | − | − | + | 1∶320 | + | + | − |
| Dog 3 | − | − | − | − | − | + | − | − |
| Dog 4 | − | − | − | − | 1∶160 | + | + | − |
| Dog 5 | − | 1∶80 | + | − | 1∶160 | − | − | − |
| Dog 6 | − | − | − | + | 1∶320 | + | + | − |
| Dog 7 | − | 1∶80 | − | + | 1∶80 | − | − | − |
| Dog 8* | − | 1∶80 | + | + | 1∶160 | − | − | + |
| Dog 9 | − | − | − | − | 1∶160 | + | − | − |
| Dog 10 | − | − | − | − | 1∶320 | − | + | − |
| Dog 11 | − | 1∶80 | + | − | 1∶640 | − | + | + |
| Dog 12 | − | 1∶80 | + | − | 1∶80 | − | − | − |
| Dog 13 | − | 1∶80 | − | − | − | − | − | − |
| Dog 14 | − | 1∶80 | + | |||||
| Dog 15 | − | − | − | − | 1∶160 | + | + | + |
| Dog 16 | − | − | − | − | − | + | − | + |
| Dog 17* | − | 1∶80 | + | + | 1∶1240 | + | + | + |
| Dog 18* | − | 1∶80 | + | − | 1∶160 | + | + | + |
| Dog 19* | − | + | − | − | 1∶320 | − | + | + |
| Dog 20 | + | − | − | − | − | − | − | − |
| Dog 21 | − | − | − | − | 1∶80 | + | − | − |
Animals displaying clinicopathological alterations suggestive for Leishmania infantum infection are marked with an asterisk.
Figure 1A dog from Group B displaying clinical signs of canine leishmaniosis.